Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q4 2024 (December 31)4holders +1
1new positions
0sold out
$12.55avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Nomura Holdings Inc. ($36.3M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($1.8M) and Jane Street Group, LLC ($771K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $771K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 647,000 shares bought and 81,681 shares sold, net +565,319 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Nomura Holdings Inc. | 0.19% | Reduce -9.6% | 772,573 | $36.3M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 1,500,000 | $1.8M |
| Jane Street Group, LLC | 0.00% | New | 647,000 | $771K |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $241K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.